Saturday, July 11, 2026

Drug profile · INN

chlorhexidine

chlorhexidine (PLAQACIDE) is an FDA-listed pharmaceutical active ingredient.

TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — chlorhexidine
Class
Route
Patents
0
Programs
8
Data quality
0.78

Quick answer

chlorhexidine (PLAQACIDE) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN chlorhexidine
Brand PLAQACIDE

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. APHP230836 Phase 3 · PARItec · Patients presenting to ENT emergencies with a unilateral sud
  2. Chlorhexidine Phase 3 · United Therapeutics Europe · Infant, Newborn, Diseases
  3. 61186372NSC2007 Phase 2 · Janssen-Cilag International N.V · EGFR-mutated Advanced or Metastatic Non-small Cell Lung Canc
  4. Chlorhexidine Phase 1 · United Therapeutics Europe · Peri-Implantitis
  5. Chlorhexidine Approved · United Therapeutics Europe · Pneumonia
  6. Chlorhexidine Approved · CRESCENT BIOPHARMA · Neonatal Infections
  7. Chlorhexidine gluconate Approved · Hospital Authority · Liver Tumors
  8. chlorhexidine acetate gargle Unknown · Peking University Biologics · Esophageal Cancer

Frequently asked questions

What is chlorhexidine?

chlorhexidine (PLAQACIDE) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for chlorhexidine?

PLAQACIDE is a marketed brand name for chlorhexidine. Check FDA Drugs@FDA for the current US label holder and prescribing information.